scynexis, inc. is a pharmaceutical company committed to the discovery, development and commercialization of novel anti-infectives to address significant. Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of SCYNEXIS, Inc. . Find 16 researchers and browse 4 departments, publications, full-texts, contact details and general information related to SCYNEXIS, Inc. | Durham. SCYNEXIS Inc. company and executive profile by Barron's. View the latest SCYX company infomation and executive bios. Sponsor of multinational clinical trial. Scynexis, Inc. Scynexis, Inc. 1 Evertrust Plaza, 13th Floor NJ JERSEY CITY UNITED STATES. Phone 1: ().
SCYX - Scynexis Inc - Stock screener for investors and traders, financial visualizations. SCYNEXIS, Inc. operates as a drug discovery and development company in the United States and internationally. SCYNEXIS Inc. ; Market Value, $M ; Shares Outstanding, M ; EPS (TTM), -$ ; P/E Ratio (TTM), N/A ; Dividend Yield, N/A. Get the latest news and real-time alerts from SCYNEXIS, Inc. (SCYX) stock at Seeking Alpha. Read More effective against drug-resistant strains of the fungi. SCYNEXIS is also working on anti-virals and it provides contract animal health R&D to third. Sponsor of multinational clinical trial. Scynexis, Inc. Scynexis, Inc. 1 Evertrust Plaza, 13th Floor NJ JERSEY CITY UNITED STATES. Phone 1: (). SCYNEXIS, Inc. Post Office Box Research Triangle Park, NC United States Phone: () Website: psychiatry-therapy.ru SCYNEXIS Inc. balance sheet, income statement, cash flow, earnings & estimates, ratio and margins. View SCYX financial statements in full. About the company. SCYNEXIS, Inc. is a biotechnology company. It is pioneering medicine to overcome and prevent difficult-to-treat and drug-resistant infections. Scynexis, Inc. Report issue ; First Clinical Trial. NCT ; First Marketed Drug. Ibrexafungerp (Brexafemme) ; First NDA Approval. Discover real-time SCYNEXIS, Inc. Common Stock (SCYX) stock prices, quotes, historical data, news, and Insights for informed trading and investment.
Information on stock, financials, earnings, subsidiaries, investors, and executives for Scynexis. Use the PitchBook Platform to explore the full profile. SCYNEXIS, Inc. (NASDAQ: SCYX) is a biotechnology company pioneering innovative medicines to help millions of patients worldwide overcome and prevent. Discover real-time SCYNEXIS, Inc. Common Stock (SCYX) stock prices, quotes, historical data, news, and Insights for informed trading and investment. Get the latest SCYNEXIS Inc. (SCYX) stock price, news, buy or sell recommendation, and investing advice from Wall Street professionals. Company. SCYNEXIS Inc. Follow. 3 results. Scynexis to recall GSK-partnered antifungal on cross contamination risk September 25, Reuters logo. Healthcare. SCYNEXIS, Inc. provides pharmaceutical products. The Company discovers, develops, and distributes intravenous drug for the treatment of serious and life-. Get the latest SCYNEXIS Inc (SCYX) real-time quote, historical performance, charts, and other financial information to help you make more informed trading. Scynexis Inc company profile analysis with the premuim data - Globaldata. SCYNEXIS Inc. Latest. Search. Search. Clear this text input. F.D.A. Approves Pricey Pill to Treat Vaginal Yeast Infections. Regulators allowed a new antifungal.
View today's Scynexis Inc stock price and latest SCYX news and analysis. Create real-time notifications to follow any changes in the live stock price. SCYNEXIS, Inc. is a biotechnology company, which engages in the development of novel oral and intravenous triterpenoid antifungal for the treatment of several. Scynexis, Inc. On this news, the Company's shares fell $, or %, to close at $ per share on September 25, , on unusually heavy trading volume. Get real-time Scynexis Inc (SCYX) stock price quotes, analyst insights, forecasts, news, and information you need to help your stock trading and investing. SCYNEXIS, Inc. (NASDAQ: SCYX) is a biotechnology company pioneering innovative medicines to help millions of patients worldwide overcome and prevent.
SCYNEXIS Inc. (SCYX). SCYNEXIS, Inc NASDAQ: SCYX is a biotechnology company developing its lead product candidate, ibrexafungerp, as a broad-spectrum. Scynexis Inc. Sector. Health Care. Industry. Pharmaceuticals. SCYNEXIS Inc is a drug development company that focuses on the development and commercialization.
Best Dating Service For Over 50 | How To Trade Stocks Course